Cargando…
A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity
BACKGROUND: Chronic Hepatitis C Virus (HCV) infection has been commonly linked to the development of autoimmunity, in part through activation of B cells. B cells are also postulated to play a pathogenic role in the autoimmune liver disease Primary Biliary Cholangitis (PBC). Patients with concurrent...
Autores principales: | Nguyen, Henry H., Khathlan, Abdullah, Fritzler, Marvin J., Swain, Mark G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019319/ https://www.ncbi.nlm.nih.gov/pubmed/29940867 http://dx.doi.org/10.1186/s12876-018-0826-7 |
Ejemplares similares
-
Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS)
por: Nguyen, Henry H., et al.
Publicado: (2018) -
Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis – a case series
por: Kolev, Mirjam, et al.
Publicado: (2023) -
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021) -
Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals
por: Alswat, Khalid, et al.
Publicado: (2022) -
A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2019)